Moreover, amyloid PET molecular imaging provides information about the complex interactions between Aβ42, Tau, and neuroinflammation in AD and mild cognitive impairment (MCI), allowing us to differentiate among the changes associated with the normal aging process or the physiopathological processes of the disease. This evidence concerns the gene MAPT and Alzheimer disease.